Literature DB >> 19263594

Mouse models of colon cancer.

Makoto Mark Taketo1, Winfried Edelmann.   

Abstract

Genetically engineered mice are essential tools in both mechanistic studies and drug development in colon cancer research. Mice with mutations in the Apc gene, as well as in genes that modify or interact with Apc, are important models of familial adenomatous polyposis. Mice with mutations in the beta-catenin signaling pathway have also revealed important information about colon cancer pathogenesis, along with models for hereditary nonpolyposis colon cancer and inflammatory bowel diseases associated with colon cancer. Finally, transplantation models (xenografts)have been useful in the study of metastasis and for testing potential therapeutics. This review discusses what models have been developed most recently and what they have taught us about colon cancer formation, progression, and possible treatment strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19263594     DOI: 10.1053/j.gastro.2008.12.049

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  107 in total

1.  Genetic and Chemical Models of Colorectal Cancer in Mice.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2010-03-10

2.  The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma.

Authors:  Kazunori Shibao; Michael J Fiedler; Jun Nagata; Noritaka Minagawa; Keiji Hirata; Yoshifumi Nakayama; Yasuko Iwakiri; Michael H Nathanson; Koji Yamaguchi
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

3.  RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

Authors:  Oghenekevwe M Gbenedio; Caroline Bonnans; Delphine Grun; Chih-Yang Wang; Ace J Hatch; Michelle R Mahoney; David Barras; Mary Matli; Yi Miao; K Christopher Garcia; Sabine Tejpar; Mauro Delorenzi; Alan P Venook; Andrew B Nixon; Robert S Warren; Jeroen P Roose; Philippe Depeille
Journal:  JCI Insight       Date:  2019-06-25

4.  A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer.

Authors:  Alexander M Betzler; Susan Kochall; Linda Blickensdörfer; Sebastian A Garcia; May-Linn Thepkaysone; Lahiri K Nanduri; Michael H Muders; Jürgen Weitz; Christoph Reissfelder; Sebastian Schölch
Journal:  J Vis Exp       Date:  2017-07-06       Impact factor: 1.355

Review 5.  Development of Preclinical Models to Understand and Treat Colorectal Cancer.

Authors:  Judith S Sebolt-Leopold
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

6.  IL-33 activates tumor stroma to promote intestinal polyposis.

Authors:  Rebecca L Maywald; Stephanie K Doerner; Luca Pastorelli; Carlo De Salvo; Susan M Benton; Emily P Dawson; Denise G Lanza; Nathan A Berger; Sanford D Markowitz; Heinz-Josef Lenz; Joseph H Nadeau; Theresa T Pizarro; Jason D Heaney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

Review 7.  Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays.

Authors:  Sundeep A Chandra; Michael W Nolan; David E Malarkey
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

Review 8.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

9.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.

Authors:  Kenneth E Hung; Marco A Maricevich; Larissa Georgeon Richard; Wei Y Chen; Michael P Richardson; Alexandra Kunin; Roderick T Bronson; Umar Mahmood; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 10.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.